This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today.
The Supreme Court considers the future of mifepristone
An overcast sky hangs above the U.S. Supreme Court.
Listen
47:13
The Supreme Court is hearing a case that will determine access to a widely-used abortion pill. At the center of the FDA v. the Alliance for Hippocratic Medicine is the drug mifepristone. It’s been approved by the FDA for over 23 years. It’s commonly used in a two-drug combination for medication abortion.
It’s the first abortion case the court has heard since it overturned Roe v. Wade. More people than ever are relying on medication abortion since states have imposed bans and restrictions on access to the procedure.A group of anti-abortion doctors and organizations brought the case against the FDA saying the drug is unsafe. The group is also asking to roll back telemedicine and mail access to pharmaceuticals.
But the case could have wide-reaching effects beyond abortion access. The FDA’s authority is also at stake.What did we learn from the oral arguments and what comes next?
Copyright 2024 WAMU 88.5. To see more, visit WAMU 88.5. 9(MDA1OTI3MjQ5MDEyODUwMTE2MzM1YzNmZA004))
You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.
Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.
If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Your tax-deductible donation keeps LAist independent and accessible to everyone.
Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.
If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief
